Carregant...
In silico modeling for quick prediction of inhibitory activity against 3CL(pro) enzyme in SARS CoV diseases
As of 2 September 2020, the 2019 novel coronavirus or SARS CoV-2 has been responsible for more than 2,56,02,665 infections and 8,52,768 deaths worldwide. There has been an urgent need of newer drug discovery to tackle the situation. Severe acute respiratory syndrome-associated coronavirus 3C-like pr...
Guardat en:
| Publicat a: | J Biomol Struct Dyn |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7544940/ https://ncbi.nlm.nih.gov/pubmed/32954984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1821779 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|